| Financier | Commitments |
|---|---|
| Global Financing Facility | 15.00 |
| IDA Credit | 29.25 |
| Pandemic Emergency Financing Facility | 0.94 |
| IDA Grant | 15.00 |
Rwanda COVID-19 Emergency Response Project
Abstract*
This project was selected for COVID-19 Fast Track Facility because of the high-level political commitment in Rwanda to protect public health, invest early, and avert the high socio-economic costs associated with outbreaks. The objectives and components are fully aligned with the COVID-19 Fast Track Facility guidelines. The project complements activities to be supported by the government and other development partners. The focus is on supporting the... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in the Republic of Rwanda, and provide immediate and effective response in the case of an eligible crisis or emergency
Key Details
Project Details
P173855
Active
Patrice Mwitende , Amparo Gordillo-Tobar
Republic of Rwanda
Rwanda
April 2, 2020
(as of board presentation)
April 7, 2020
April 20, 2020
US$ 60.19 million
Ministry of Health (MoH) / Rwanda Biomedical Center (RBC)
2020
US$ 60.19 million
N/A
June 25, 2024
June 30, 2025
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 44.25 |
| IBRD + IDA Commitment | 44.25 |
| Lending Instrument | |
|---|---|
| Grant Amount | 15.94 |
| Total Project Cost** | 60.19 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Oct 6, 2021 | IDA-D8050 | Loan Disb | 452,593.66 |
| Feb 10, 2022 | IDA-68710 | Loan Disb | 453,354.16 |
| Jun 1, 2022 | IDA-68710 | Int Charges | 51,110.60 |
| Jul 15, 2022 | IDA-66150 | Int Charges | 49,414.84 |
| Jul 15, 2022 | IDA-66150 | Int Charges | 49,414.84 |
| Dec 22, 2021 | IDA-68710 | Loan Disb | 480,500.44 |
| Nov 16, 2021 | IDA-68710 | Loan Disb | 296,319.03 |
| Sep 27, 2021 | IDA-68710 | Loan Disb | 7,864,447.50 |
| Oct 6, 2021 | IDA-66150 | Loan Disb | 460,803.25 |
| Aug 12, 2021 | IDA-68710 | Loan Disb | 252,000.02 |
| Aug 16, 2023 | IDA-70920 | Loan Disb | 588,312.75 |
| Jul 15, 2023 | IDA-66150 | Int Charges | 55,118.25 |
| Jul 15, 2023 | IDA-66150 | Int Charges | 55,118.25 |
| Jun 28, 2023 | IDA-70920 | Loan Disb | 1,213,908.20 |
| Jun 1, 2023 | IDA-68710 | Int Charges | 1,619.02 |
| Jun 1, 2023 | IDA-68710 | Int Charges | 1,619.02 |
| Jun 1, 2023 | IDA-68710 | Int Charges | 52,183.71 |
| Jun 1, 2023 | IDA-68710 | Int Charges | 52,183.71 |
| Jun 2, 2023 | IDA-70920 | Loan Disb | 422,492.60 |
| May 1, 2023 | IDA-70920 | Int Charges | 2,526.29 |
| May 1, 2023 | IDA-70920 | Int Charges | 2,526.29 |
| Apr 28, 2023 | IDA-70920 | Loan Disb | 970,297.00 |
| Apr 28, 2023 | IDA-70920 | Loan Disb | 473,915.97 |
| Oct 31, 2022 | IDA-66150 | Loan Cancel | 1.64 |
| Jan 17, 2023 | IDA-66150 | Int Charges | 53,217.11 |
| Jan 17, 2023 | IDA-66150 | Int Charges | 53,217.11 |
| Feb 8, 2023 | IDA-70920 | Loan Disb | 776,570.80 |
| Jan 26, 2023 | IDA-70920 | Loan Disb | 973,184.20 |
| May 1, 2023 | IDA-70920 | Int Charges | 16,534.86 |
| May 1, 2023 | IDA-70920 | Int Charges | 16,534.86 |
| Jan 15, 2024 | IDA-66150 | Int Charges | 53,769.77 |
| Jan 15, 2024 | IDA-66150 | Int Charges | 53,769.77 |
| Feb 23, 2024 | IDA-70920 | Loan Disb | 1,476,602.50 |
| May 1, 2024 | IDA-70920 | Int Charges | 36,048.81 |
| Jul 15, 2024 | IDA-66150 | Int Charges | 53,013.28 |
| Jul 15, 2024 | IDA-66150 | Int Charges | 53,013.28 |
| Jun 1, 2024 | IDA-68710 | Int Charges | 51,931.02 |
| Jun 1, 2024 | IDA-68710 | Int Charges | 51,931.02 |
| Jun 1, 2024 | IDA-68710 | Int Charges | 673.58 |
| Jun 1, 2024 | IDA-68710 | Int Charges | 673.58 |
| Dec 1, 2021 | IDA-68710 | Int Charges | 24,514.06 |
| Sep 16, 2020 | IDA-66150 | Loan Disb | 572,898.90 |
| Aug 21, 2020 | IDA-66150 | Loan Disb | 590,150.00 |
| Apr 22, 2021 | IDA-66150 | Loan Disb | 108,774.46 |
| Jan 15, 2021 | IDA-66150 | Int Charges | 7,675.77 |
| Jan 15, 2021 | IDA-66150 | Int Charges | 7,675.77 |
| Jan 15, 2021 | IDA-66150 | Int Charges | 44,154.61 |
| Jan 15, 2021 | IDA-66150 | Int Charges | 44,154.61 |
| Oct 21, 2021 | IDA-66150 | Loan Disb | 107,089.22 |
| Aug 6, 2021 | IDA-66150 | Loan Disb | 141,201.23 |
| Aug 12, 2021 | IDA-68710 | Loan Disb | 252,000.02 |
| Jun 28, 2021 | IDA-68710 | Loan Disb | 3,632,850.00 |
| Jul 15, 2021 | IDA-66150 | Int Charges | 198.09 |
| Jul 15, 2021 | IDA-66150 | Int Charges | 198.09 |
| Jul 15, 2021 | IDA-66150 | Int Charges | 53,884.63 |
| Jul 15, 2021 | IDA-66150 | Int Charges | 53,884.63 |
| Aug 6, 2021 | IDA-68710 | Loan Disb | 59,022.50 |
| Aug 21, 2020 | IDA-66150 | Loan Disb | 577,428.56 |
| May 26, 2020 | IDA-66150 | Loan Disb | 547,700.00 |
| Jun 3, 2020 | IDA-66150 | Loan Disb | 7,450,419.50 |
| Sep 2, 2020 | IDA-66150 | Loan Disb | 1,089,309.80 |
| Dec 30, 2020 | IDA-66150 | Loan Disb | 658,280.80 |
| Nov 30, 2022 | IDA-70920 | Loan Disb | 724,525.10 |
| Nov 18, 2022 | IDA-70920 | Loan Disb | 117,254.43 |
| Sep 6, 2022 | IDA-70920 | Loan Disb | 1,987,784.10 |
| Dec 1, 2022 | IDA-68710 | Int Charges | 1,186.26 |
| Dec 1, 2022 | IDA-68710 | Int Charges | 1,186.26 |
| Dec 1, 2022 | IDA-68710 | Int Charges | 49,031.68 |
| Dec 1, 2022 | IDA-68710 | Int Charges | 49,031.68 |
| Dec 22, 2022 | IDA-70920 | Loan Disb | 753,272.06 |
| Jun 1, 2022 | IDA-68710 | Int Charges | 120.05 |
| Jun 1, 2022 | IDA-68710 | Int Charges | 120.05 |
| Jun 1, 2022 | IDA-68710 | Int Charges | 51,110.60 |
| Mar 17, 2022 | IDA-68710 | Loan Disb | 292,040.12 |
| Dec 10, 2021 | IDA-68710 | Loan Disb | 311,230.28 |
| Dec 10, 2021 | IDA-68710 | Loan Disb | 155,133.92 |
| Jan 13, 2022 | IDA-68710 | Loan Disb | 193,283.98 |
| Jan 15, 2022 | IDA-66150 | Int Charges | 54,612.48 |
| Jan 15, 2022 | IDA-66150 | Int Charges | 54,612.48 |
| Dec 1, 2023 | IDA-68710 | Int Charges | 616.92 |
| Dec 1, 2023 | IDA-68710 | Int Charges | 616.92 |
| Dec 1, 2023 | IDA-68710 | Int Charges | 50,978.24 |
| Dec 1, 2023 | IDA-68710 | Int Charges | 50,978.24 |
| Jul 25, 2024 | IDA-70920 | Loan Disb | 363,614.84 |
| Nov 1, 2023 | IDA-70920 | Int Charges | 86.68 |
| Nov 1, 2023 | IDA-70920 | Int Charges | 86.68 |
| Nov 1, 2023 | IDA-70920 | Int Charges | 30,703.42 |
| Nov 1, 2023 | IDA-70920 | Int Charges | 30,703.42 |
| May 1, 2024 | IDA-70920 | Int Charges | 36,048.81 |
| Jun 4, 2024 | IDA-70920 | Loan Disb | 308,509.50 |
| May 1, 2024 | IDA-66150 | Loan Disb | -369,233.84 |
| Apr 16, 2021 | IDA-68710 | Loan Commitment | 15,000,000.00 |
| Apr 16, 2021 | IDA-D8050 | Loan Commitment | 15,000,000.00 |
| Mar 31, 2022 | IDA-70920 | Loan Commitment | 16,000,000.00 |
| Mar 31, 2022 | IDA-E0220 | Loan Commitment | 16,000,000.00 |
| Apr 7, 2020 | IDA-66150 | Loan Commitment | 14,250,000.00 |
| Feb 20, 2024 | IDA-E0220 | Loan Disb | 2,529,674.80 |
| Jul 22, 2024 | IDA-E0220 | Loan Disb | 204,668.77 |
| May 30, 2024 | IDA-E0220 | Loan Disb | 9,842.50 |
| Aug 10, 2023 | IDA-E0220 | Loan Disb | 526,812.40 |
| Jun 23, 2023 | IDA-E0220 | Loan Disb | 773,044.44 |
| May 30, 2023 | IDA-E0220 | Loan Disb | 112,840.06 |
| Aug 31, 2022 | IDA-E0220 | Loan Disb | 3,000,000.00 |
| Nov 15, 2022 | IDA-E0220 | Loan Disb | 805,502.60 |
| Jan 23, 2023 | IDA-E0220 | Loan Disb | 683,323.90 |
| Apr 25, 2023 | IDA-E0220 | Loan Disb | 133,646.25 |
| Apr 21, 2023 | IDA-E0220 | Loan Disb | 180,856.98 |
| Feb 6, 2023 | IDA-E0220 | Loan Disb | 2,304,301.20 |
| Dec 10, 2021 | IDA-D8050 | Loan Disb | 196,928.12 |
| Dec 19, 2022 | IDA-E0220 | Loan Disb | 816,928.94 |
| Nov 23, 2022 | IDA-E0220 | Loan Disb | 810,975.80 |
| Nov 12, 2021 | IDA-D8050 | Loan Disb | 229,000.00 |
| Oct 21, 2021 | IDA-D8050 | Loan Disb | 191,198.77 |
| Oct 21, 2021 | IDA-D8050 | Loan Disb | 456,585.62 |
| Oct 28, 2021 | IDA-D8050 | Loan Disb | 1,207,508.60 |
| Aug 6, 2021 | IDA-D8050 | Loan Disb | 59,022.50 |
| Jun 28, 2021 | IDA-D8050 | Loan Disb | 8,631,382.00 |
| Jun 22, 2021 | IDA-D8050 | Loan Disb | 3,500,640.00 |
| Feb 11, 2021 | IDA-66150 | Loan Disb | 543,207.06 |
| Oct 8, 2020 | IDA-66150 | Loan Disb | 958,262.70 |
| Nov 4, 2020 | IDA-66150 | Loan Disb | 983,767.90 |
| Aug 4, 2021 | IDA-68710 | Loan Disb | 846,720.00 |
| Aug 4, 2021 | IDA-68710 | Loan Disb | -846,720.00 |
| Aug 12, 2021 | IDA-68710 | Loan Disb | -252,000.02 |
| Aug 4, 2021 | IDA-68710 | Loan Disb | 846,720.00 |
| Nov 12, 2021 | IDA-66150 | Loan Disb | 248,293.25 |
| Dec 1, 2021 | IDA-68710 | Int Charges | 24,514.06 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2024-11-26 |
| Monitoring and Evaluation | Satisfactory | 2024-11-26 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-11-26 |
| Procurement | Moderately Satisfactory | 2024-11-26 |
| Financial Management | Moderately Satisfactory | 2024-11-26 |
| Project Management | Moderately Satisfactory | 2024-11-26 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of suspected cases of COVID-19 reported and investigated based on national guidelines Value 80.00 100.00 100.00 Date April 7, 2020 February 15, 2024 June 30, 2025 Comment Percentage of population 18 years and above receiving a booster, which is included in the population targets defined in the national plan, disaggregated by sex Value 0.00 79.70 56.00 Date February 28, 2022 February 15, 2024 June 30, 2025 Comment Number of designated laboratories with COVID-19 diagnostic capacity Value 1.00 156.00 151.00 Date April 7, 2020 March 31, 2023 June 30, 2025 Comment Percentage of the population fully vaccinated which is included in the priority population targets as defined in the national plan disaggregated by sex, age group and location. Value 0.00 79.90 86.00 Date February 5, 2021 February 15, 2024 June 30, 2025 Comment Proportion of designated healthcare facilities with isolation capacity Value 20.00 100.00 100.00 Date April 7, 2020 February 15, 2024 June 30, 2025 Comment Number of doses of COVID-19 vaccine procured with Project funding Value 0.00 3601440.00 6000000.00 Date January 29, 2021 March 31, 2023 June 30, 2025 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Proportion of targeted healthcare facilities with clinical capacity for COVID-19 patients Value 20.00 100.00 100.00 Date April 7, 2020 February 15, 2024 June 30, 2023 Comment Number of mass media campaigns on COVID-19 prevention and vaccination Value 0.00 96.00 90.00 Date February 5, 2021 March 31, 2023 June 30, 2023 Comment Number of people screened for underlying chronic conditions, disaggregated sex and age group Value 0.00 2164274.00 300000.00 Date March 8, 2021 February 15, 2024 June 30, 2025 Comment Number of outpatient consultations, disaggregated by age and sex Value 18860619.00 11185624.00 19622500.00 Date March 24, 2021 December 31, 2023 June 30, 2025 Comment Percentage of grievances documented, processed and resolved within 30 days Value 0.00 100.00 100.00 Date October 20, 2020 February 15, 2024 June 30, 2025 Comment Number of health staff trained in infection prevention and control Value 20.00 3554.00 2000.00 Date April 7, 2020 March 31, 2023 June 30, 2023 Comment Percentage of targeted hospitals with functioning oxygen therapy system Value 0.00 100.00 100.00 Date March 8, 2021 February 15, 2024 June 30, 2023 Comment Number of new acceptors of modern contraception Value 238392.00 170646.00 248023.00 Date March 24, 2021 December 31, 2023 June 30, 2023 Comment Total tests performed by the Government facilities, disaggregated by sex Value 0.00 3634311.00 0.00 Date October 20, 2020 March 31, 2023 June 30, 2025 Comment Number of deliveries conducted within the facility Value 315814.00 192086.00 328573.00 Date March 24, 2021 December 31, 2023 June 30, 2023 Comment Proportion of serious Adverse events following immunization (AEFI) reported and investigated, by sex Value 0.00 78.00 95.00 Date February 5, 2021 March 31, 2023 June 30, 2025 Comment Number of pregnant women receiving four antenatal care visits Value 0.00 104071.00 190280.00 Date March 24, 2021 December 31, 2023 June 30, 2023 Comment Number of infants receiving Pentavalent 3 vaccine Value 345423.00 197237.00 352330.00 Date March 24, 2021 December 31, 2023 June 30, 2023 Comment Number of laboratory staff trained to conduct COVID-19 diagnosis Value 0.00 192.00 50.00 Date April 7, 2020 March 31, 2023 June 30, 2023 Comment